The government is considering increasing healthcare costs to save 700 million euros by introducing a pharmacy deductible and doubling the limits.
At the dawn of 2025, the French healthcare system finds itself at a crossroads between maintaining quality of care and budgetary constraints. To improve its finances, the government proposes a major reform aimed at increasing costs borne by patients by doubling the annual caps on medical deductibles and flat-rate contributions, as well as introducing direct payment of deductibles at pharmacy counters. These measures aim to save 700 million euros in the upcoming fiscal year while seeking to hold users accountable. Nevertheless, this strategy elicits mixed reactions among healthcare professionals, patient associations, and players in the pharmaceutical sector, including major laboratories like Sanofi, Pfizer, or Roche.
Among the targeted measures is the deductible on medicines, which will profoundly change the patient’s journey through its payment mode. This reform fits into a broader context of controlling public healthcare expenses, with recovery targets set in the billions of euros. Debates flare around balancing necessary savings with equitable access to care, raising questions about the real impact on citizens, especially the most vulnerable.
Doubling the cap on medical deductibles: mechanisms and implications for patients
The government plans to raise the annual cap on medical deductibles from 50 to 100 euros per insured, a doubling that applies equally to deductibles and flat-rate contributions, whose combined annual caps could reach 200 euros per person. This increase marks a turning point in healthcare financing policy, with Social Security reducing its reimbursement share, thereby mechanically increasing out-of-pocket expenses for users.
The deductibles cover a wide range of expenses: medicines, medical consultations, paramedical care, radiological exams, biological analyses, and ambulance transports. Concretely, this means that previously, a patient paid about 100 euros maximum per year for these deductibles. From 2025, for the same volume of care, this amount could double, potentially reaching 200 euros—a larger burden on household budgets.
It is worth noting that these deductibles are not covered by the additional “responsible” health insurance contracts, which cover more than 98% of health mutuals. This implies that despite using supplementary insurance, these deductibles remain the effective responsibility of patients, representing a clear withdrawal of the Health Insurance’s support. This mechanism primarily aims to make insured individuals more responsible in their medical consumption, encouraging more thoughtful use of care.
The current operation of deductibles: practices with pointed limits
Traditionally, medical deductibles are indirectly deducted from reimbursements made by Social Security. The insured does not pay an additional amount in pharmacy or during consultations but notices a slight deduction on their reimbursements. This operation mode has the advantage of administrative simplicity but does not create a visible reference point for the patient regarding the actual cost of their care.
This system has fostered a certain perception of “illusion of everything being free,” criticized by several actors such as employers and the government. The absence of an explicit disbursement allegedly hampers the responsibility of insured individuals, who tend to sometimes consume unnecessary care.
The proposed reform aims to correct this by making visible the payment at the counter, akin to the purchase price of medicines. This shift could modify behaviors by introducing a financial friction during purchase or medical visits, thereby limiting excessive spending.
| Current | 2025 Proposal | Impact on the patient |
|---|---|---|
| Annual cap on medical deductibles | 50 € | Rising to 100 €, doubling |
| Annual cap on flat-rate contributions | 50 € | Rising to 100 €, also doubling |
| Reimbursements for responsible mutuals | No | No change, remains effectively at patient’s charge |
| Indirect payment via Health Insurance | Direct payment at pharmacy counter envisaged | More visible and tangible for the user |
Economic impact on the health system and expense reduction strategies
Aiming to save 700 million euros, the government incorporates this measure into the broader budgetary reforms in health for 2025. This component is part of a savings plan that could reach up to 5.5 billion euros in health expenditure, involving a massive structural adjustment.
These measures respond to a context of massive financial imbalance. The Health Insurance faces a continuous increase in its expenses, with persistent risks of exceeding the ceiling at the national level. Rising costs of treatments provided by major pharmaceutical groups such as Bayer, Novartis, GSK, Merck, or AstraZeneca also weigh on these balances.
By opting for a doubling of deductibles, the government aims both to reduce reimbursements and to favor a more frugal use of medical resources, a key aspect in controlling healthcare expenses. This action is partly justified by recurrent criticisms of the “full reimbursement” system, which does not promote optimized use of care.
Key actors involved in this reform
- 🏥 Patients, who will have to bear higher out-of-pocket costs
- 💉 Pharmacies, facing new management of deductibles and collections
- 🏦 Health Insurance, seeking budgetary recovery
- 📊 Mutuals, mainly responsible, which need to adapt their offerings
- 🏢 Pharmaceutical laboratories such as Pfizer, Roche, AbbVie, Johnson & Johnson
This evolution also impacts healthcare professionals, some of whom point out administrative complexity and the risk of tensions with patients now more exposed to direct payments. According to BFMTV, implementing a payment at the counter could also generate disputes over the administrative and financial burden borne by pharmacies.
Consequences for patients and vulnerable groups: a risk highlighted by associations
The projected measures are likely to weigh heavily on certain already vulnerable user profiles. Among them are people with long-term illnesses (ALD), who benefit from close monitoring but are not exempt from these deductibles, although specific rules apply.
Furthermore, populations such as seniors, often concerned with repeated treatments and multiple consultations, risk seeing their out-of-pocket costs significantly increase. The issue of financial accessibility to care has also been raised by unions and patient federations, such as France Asso Santé.
The double burden could also affect chronic patients who do not benefit from full exemptions, as well as families with modest incomes. These criticisms point to an increased risk of care abandonment or delayed care due to perceived high costs.
| Patient category | Situation in 2024 | Effects of doubling in 2025 |
|---|---|---|
| People with long-term illnesses (ALD) | Partially exempted, still deductibles apply | Risk of increased costs despite monitoring |
| Older adults and seniors | Multiple care, already high costs | Increased out-of-pocket costs, higher financial burden |
| Low-income families | Maintaining specific exemptions | Potential care abandonment due to lack of resources |
| Patients without mutual insurance or non-responsible contracts | Significant out-of-pocket costs | Greater exposure to direct expenses |
In this context, several associations call for increased vigilance and open dialogue around the implementation conditions. The debate also extends to the responsibility of doctors in prescriptions and the actual effectiveness of this financial responsibility, questioning the appropriateness of transferring all costs solely onto patients.
Direct payment at pharmacy counters: practical updates and implementation challenges
The most notable novelty in this project is undoubtedly the introduction of immediate payment of the deductible at the time of purchase in pharmacy. This method stops the principle of post-reimbursement deduction and involves physical presence for a financial transaction.
Technically, this modification requires adapting pharmacy software as well as internal procedures to ensure transparent management in compliance with Social Security rules. A precise and individualized calculation of the deductibles reached during the year will be necessary to avoid exceeding the mentioned caps.
Patients will have to pay a flat amount at the counter, proportional to the care or medicines concerned, which could change their purchasing behavior. This change also introduces new challenges for pharmacists, who fear administrative overload and tensions with clients. Resistance within the pharmacy network could also occur.
- 📋 Need for software adjustments and professional training
- ⏳ Possible slowdown of pharmacy services
- 📉 Changes in patient consumption habits
- ⚠️ Risk of exclusion due to missed or non-immediate payments
- 💼 Impact on daily management of pharmacies
This transformation also demands effective coordination between healthcare professionals and authorities, to prevent inefficiency or conflicts with users. Additionally, a direct payment to physicians (flat-rate contribution) might be considered, although it would add to the administrative load on the medical sector.
Recent history of medical deductibles: progression and protests
It is important to place this new step within a recent history marked by successive increases in flat-rate amounts and daily caps. In 2024, deductibles for medicines doubled, from €0.50 to €1, while those for ambulance transports jumped from €2 to €4.
Simultaneously, flat-rate contributions for consultations and additional examinations also increased, doubling from, for example, €1 to €2 since May 2024.
These increases have generated growing dissatisfaction among patients and associations, who denounce an aggravation of healthcare costs contrary to the original goal of a solidarity system.
Until now, the government had not touched the annual caps, but this step in 2025 represents an intensification of the movement.
This dynamic raises many questions about economic sustainability for households and the consistency of health policy, especially in a context where major pharmaceutical actors like Sanofi or GSK play a key role in the reimbursed medication market.
| Evolution of deductibles | Amount before 2024 | Amount in 2024 | Project for 2025 |
|---|---|---|---|
| Medicine deductible | 0.50 € | 1 € | Potential for 2 € |
| Transport deductible | 2 € | 4 € | (remains 4 €) |
| Consultation flat-rate participation | 1 € | 2 € | (remains 2 €) |
| Daily caps | – | Doubling (4 € to 8 € depending on category) | (no planned change) |
In response to protests, some government officials nevertheless emphasize the necessity of these measures within a “responsibilization” policy for users, whose results will need careful evaluation.
The debate has also moved towards the possibility of establishing deductibles on certain medical devices, a project suspended due to lack of parliamentary agreement.
The role of health mutuals in the face of increased deductibles and caps
Alongside these measures, health mutuals are on the front line to support insured individuals facing the announced rise in costs. However, the responsible contracts that cover the majority limit their capacity to cover deductibles, leaving a significant out-of-pocket burden.
For 2025, reforms are under consideration to propose new health insurance products better suited to regulatory changes, especially for seniors, a group particularly impacted by increased expenses.
The mutuals will need to:
- 💡 Redesign their offerings to better cover deductible-related expenses
- 📊 Adjust guarantees regarding annual caps
- 🛠️ Incorporate more prevention and patient support
- 🔄 Collaborate closely with authorities to limit care abandonment
- 📈 Manage economic impact on premiums and the market
Discussions between the government and mutual sector actors, reported by Franceinfo, show a desire for innovation in support solutions, particularly around chronic care and innovative medicines distributed by laboratories such as AbbVie or Johnson & Johnson.
Political and social issues surrounding this reform of medical deductibles
Beyond economic and health impacts, these measures are set against a tense social and political backdrop. The debate over the reform of medical deductibles highlights key issues: solidarity, equity, and governance of the public health system.
The opponents of the reform criticize an indirect increase in inequalities, pointing to actions that could undermine social cohesion. The question of patient responsibility is central to the debate, with Minister Catherine Vautrin affirming that “no one chooses to be sick, but we want to make insured individuals more responsible” (Le Monde).
However, unions such as Unsa and associations like France Asso Santé question the relevance of adding financial constraints to patients without simultaneous action on medical prescribing.
The paradox of a supposedly universal and free health system gradually imposing financial barriers calls into question the very principles on which Social Security was founded.
- ⚖️ Debate on equity and equal access to care
- 📢 Demonstrations and possible legal recourse
- 🔄 Proposal for complementary reforms on medical prescription
- 📉 Risks of increased exclusion for certain populations
- 🏛️ Political pressures to preserve a balanced system
Finally, this debate also affects political decision-makers, faced with the trade-off between budgetary discipline and maintaining quality and social justice. These discussions will be decisive in shaping health policies in the coming years.
Complementary measures under consideration and alternative avenues to control healthcare costs
Beyond doubling caps and changing the payment mode, the government is exploring other avenues to strengthen financial recovery without excessively burdening patients.
Among these options are:
- 🏥 Reducing excessive prescriptions by strengthening medical responsibility
- 📉 Limiting reimbursements for certain costly medical devices
- 🩺 Promoting generics and biosimilar medicines from laboratories like Novartis and Bayer
- 🔍 Fighting fraud and abuse in the healthcare system
- 📋 Optimizing care pathways through telemedicine and digital tools
Another debated option involves establishing a specific deductible on medical devices such as dressings or implants, an idea estimated to potentially save up to 340 million euros. However, regulatory complexity and parliamentary opposition have led to the suspension of this reform, pending further consultation.
This is within the scope of large pharmaceutical companies, including Roche and AstraZeneca, which remain attentive to evolving policies and adapt their business strategies accordingly.
| Envisaged measures | Objectives | Expected impacts |
|---|---|---|
| Strengthening medical prescriptions | Limit unnecessary care | Reduce unneeded expenses |
| Promoting generics medicines | Lower treatment costs | Budget balance |
| Deductible on medical devices (suspended) | Reduce associated expenses | Limited savings, unlikely to be adopted |
| Digital optimization of care pathways | Improve efficiency | Better coordination, fewer redundancies |
| Fight fraud | Preserve resources | Significant gains over medium term |
FAQ: key questions about doubling medical deductibles and their consequences
- ❓ What is a medical deductible?
A medical deductible is a fixed amount deducted from reimbursements by Social Security for certain care and products that the patient must finance. - ❓ Why double the annual caps?
The government aims to limit healthcare expenses by making insured individuals more responsible and reducing the burden on the Health Insurance. - ❓ Do mutuals cover the deductible?
No, responsible contracts covering 98% of insured individuals do not reimburse medical deductibles. - ❓ Which patients are protected from deductibles?
Minors, beneficiaries of Complementary Health Solidarity, pregnant women from the 6th month of pregnancy, and victims of acts of terrorism are exempted. - ❓ What is the impact on chronic patients and seniors?
They face an increased out-of-pocket expense that could complicate access to care, requiring strengthened support.
Source: www.bfmtv.com
Entraîne-toi avec nos Quiz de révision
Fini les lectures passives. Pour retenir les notions clés du BTS Assurance, teste-toi ! Inscris-toi pour recevoir 1 quiz par jour directement dans ta boîte mail.
